Restylane Shaype Wins EU Green Light for Chin Augmentation
The EU has cleared Restylane Shaype for chin augmentation, moving a long-requested indication from off-label territory into the on-label toolkit for European aesthetic clinics.
Topic
Topic
The EU has cleared Restylane Shaype for chin augmentation, moving a long-requested indication from off-label territory into the on-label toolkit for European aesthetic clinics.
University of Miami clinicians are building infrastructure — training, complication pathways, patient education — to reduce harm…
The FDA has approved BELOTERO VOLUME (+) and BELOTERO INTENSE (+), expanding the hyaluronic acid filler portfolio — but label det…
Collagen-stimulating fillers may provoke delayed foreign body granulomas — nodular immune reactions with no reversal agent, raisi…
Allergan Aesthetics has launched HArmonyCa with lidocaine in Canada, pairing hyaluronic acid with calcium hydroxylapatite. Trial…
Ontario's nursing regulator is moving to ban unsupervised Botox and dermal-filler injections at medical spas, the Toronto Star re…
Evolus confirmed plans to bring its Estyme hyaluronic acid injectable filler line to Europe, marking the company's first dermal f…
Hugel is funding physician-led research to build the clinical evidence base behind Korean aesthetic medicine as it competes globa…
Hugel targets 1 trillion won in sales within three years, staking its growth plan on the Korean aesthetics maker's injectable por…
A Business of Fashion profile examines Teoxane's integrated strategy across filler development, distribution and clinician traini…